دورية أكاديمية
Selenoprotein GPX3 is a novel prognostic indicator for stomach adenocarcinoma and brain low-grade gliomas: Evidence from an integrative pan-cancer analysis.
| العنوان: | Selenoprotein GPX3 is a novel prognostic indicator for stomach adenocarcinoma and brain low-grade gliomas: Evidence from an integrative pan-cancer analysis. |
|---|---|
| المؤلفون: | Wang, Yuetong, Fu, Guotao, Chen, Xueqin, Xia, Zengrun, Qi, Meng, Du, Xiaoping, Liu, Kun, Liu, Qiling, Sun, Na, Shi, Chuandao, Qu, Kai, Zhang, Rongqiang |
| المصدر: | Heliyon ; ISSN:2405-8440 ; Volume:10 ; Issue:11 |
| بيانات النشر: | PubMed Central |
| سنة النشر: | 2024 |
| المجموعة: | PubMed Central (PMC) |
| مصطلحات موضوعية: | Biomarkers, Glutathione peroxidase 3 (GPX3), Selenoprotein, Tumors |
| الوصف: | The antioxidant enzyme GPX3 is a selenoprotein that transports selenium in blood and maintains its levels in peripheral tissues. Aberrant GPX3 expression is strongly linked to the development of some tumors. However, there is a scarcity of studies examining the pan-cancer expression patterns and prognostic relevance of GPX3. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | https://doi.org/10.1016/j.heliyon.2024.e32271Test; https://pubmed.ncbi.nlm.nih.gov/38873671Test; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170152Test/ |
| DOI: | 10.1016/j.heliyon.2024.e32271 |
| الإتاحة: | https://doi.org/10.1016/j.heliyon.2024.e32271Test https://pubmed.ncbi.nlm.nih.gov/38873671Test https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11170152Test/ |
| حقوق: | © 2024 The Authors. Published by Elsevier Ltd. |
| رقم الانضمام: | edsbas.8C7C0FF0 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.heliyon.2024.e32271 |
|---|